Laura N. Kibuuka

Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics

B. Hyman, P. McLean, Z. Fan, 2014, PloS one.

Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats

A. Pollack, Laura N. Kibuuka, Jonathan D. Drake, 2013, Pharmacology Biochemistry and Behavior.

Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not α-Synuclein-Induced Neuronal Cell Loss

Nikolaus R. McFarland, P. McLean, Z. Fan, 2014, PloS one.

Direct detection of alpha synuclein oligomers in vivo

Nikolaus R. McFarland, Suneil K. Kalia, B. Hyman, 2013, Acta neuropathologica communications.